Scarica l'app Stockscreener
3.57
0.28%
-0.01
Ataibeckley Inc Borsa (ATAI) Ultime notizie
Here’s what analysts are saying about AtaiBeckley Inc. (ATAI) - MSN
Here's What Analysts Are Saying About AtaiBeckley Inc. (ATAI) - Finviz
Here’s What Analysts Are Saying About AtaiBeckley Inc. (ATAI) - Insider Monkey
AtaiBeckley Inc. (ATAI) Gains Momentum With Promising BPL-003 Data and Strong Analyst Support - Insider Monkey
5 Psychedelic Stocks to Buy Now - The Motley Fool
Guggenheim, JonesResearch Coverage and BPL-003 Control Might Change The Case For Investing In AtaiBeckley (ATAI) - simplywall.st
HC Wainwright remains bullish on AtaiBeckley Inc. (ATAI) - MSN
AtaiBeckley Inc. (ATAI) Stock Analysis: A 219.60% Upside Potential In Innovative Mental Health Treatments - DirectorsTalk Interviews
7 Best Fast Growing Penny Stocks to Buy According to Analysts - Insider Monkey
Guggenheim Initiates Buy Rating for AtaiBeckley (ATAI) With $11 PT, Cites Leadership in Psychiatry - Insider Monkey
H.C. Wainwright Remains Bullish on AtaiBeckley Inc. (ATAI) - Insider Monkey
Ataibeckley completes redomiciliation to the US - MSN
AtaiBeckley Inc. (ATAI) Stock Analysis: A Biotech Gem With Over 200% Upside Potential - DirectorsTalk Interviews
Psychedelic: Analyst initiates Atai Beckley with Buy rating - TipRanks
Assessing AtaiBeckley (ATAI) Valuation After Recent Share Price Pullback - simplywall.st
Small cap wrap: American Resources, C3 Metals, TNR Gold, AtaiBeckley... - Proactive Investors
Assessing AtaiBeckley (ATAI) Valuation After Trial Success Index Addition Capital Raise And US Move - Yahoo Finance
AtaiBeckley seen as key beneficiary of Spravato’s strong growth: Jefferies - Proactive financial news
AtaiBeckley Weighs Late Stage Options After Milestones And US$300m Raise - simplywall.st
The Bull Case For AtaiBeckley (ATAI) Could Change Following Promising BPL-003 Phase 2b Depression Data - Yahoo Finance
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026 - Finviz
Atai Beckley N.V. (ATAI) Achieves Significant Milestone on Pipeline Development and Corporate Foundation - Finviz
Assessing AtaiBeckley (ATAI) After A 149% Year Following Biotech Sector Sentiment Shift - simplywall.st
Is AtaiBeckley (ATAI) Turning Psychedelic Trial Momentum Into a Durable Mental Health Moat? - simplywall.st
Interesting ATAI Call Options For March 20th - Nasdaq
Atai Beckley announces presentations at ACNP - TipRanks
Small cap wrap: Nextech3D.ai, Aftermath Silver, Tiziana Life Sciences, AtaiBeckley… - Proactive financial news
AtaiBeckley shares clinical and preclinical data at ACNP Annual Meeting - Proactive financial news
AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation - Investing News Network
AtaiBeckley Inc. Showcases Breakthrough Findings on BPL-003 for Treatment-Resistant Depression at ACNP Annual Meeting - Quiver Quantitative
Single-dose nasal spray shows rapid effect in hard-to-treat depression - Stock Titan
A Look At AtaiBeckley (ATAI) Valuation After Phase 2b Progress And Delaware Redomiciliation - simplywall.st
Atai Beckley N.V. (ATAI) is a Buy on Mental Therapeutics Opportunities - Finviz
10 Best Penny Stocks to Buy for 2026 - Insider Monkey
AtaiBeckley Completes Redomiciliation to the United States - Investing News Network
New Strong Sell Stocks for Jan. 13 - The Globe and Mail
atai Life Sciences stock rating reiterated by Cantor Fitzgerald - Investing.com
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio - Investing News Network
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):